TLF Q1 2026 Earnings Modest Profit Amid Quiet Quarter MaxCyte Q1 2026 Earnings EPS Beat Highlights Operational Cost Discipline Amid Revenue Disclosure Gaps RCAT Q1 2026 Earnings EPS Misses Estimates as Stock Gains 421 Kalaris Therapeutics Inc KLRS Q1 2026 Earnings NarrowerthanExpected Loss Highlights Disciplined Spending HGTY Q1 2026 Earnings EPS Slightly Beats Estimate as Company Navigates Growth Investments IPAR Q1 2026 Earnings Strong EPS Beat Highlights Robust Fragrance Demand Amid Market Challenges